Correlation Between Lyell Immunopharma and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Lyell Immunopharma and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyell Immunopharma and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyell Immunopharma and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Lyell Immunopharma and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyell Immunopharma with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyell Immunopharma and Mineralys Therapeutics,.
Diversification Opportunities for Lyell Immunopharma and Mineralys Therapeutics,
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lyell and Mineralys is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Lyell Immunopharma and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Lyell Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyell Immunopharma are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Lyell Immunopharma i.e., Lyell Immunopharma and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Lyell Immunopharma and Mineralys Therapeutics,
Given the investment horizon of 90 days Lyell Immunopharma is expected to generate 1.71 times more return on investment than Mineralys Therapeutics,. However, Lyell Immunopharma is 1.71 times more volatile than Mineralys Therapeutics, Common. It trades about -0.02 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.04 per unit of risk. If you would invest 109.00 in Lyell Immunopharma on August 25, 2024 and sell it today you would lose (14.00) from holding Lyell Immunopharma or give up 12.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyell Immunopharma vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Lyell Immunopharma |
| Mineralys Therapeutics, |
Lyell Immunopharma and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyell Immunopharma and Mineralys Therapeutics,
The main advantage of trading using opposite Lyell Immunopharma and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyell Immunopharma position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Lyell Immunopharma vs. Eliem Therapeutics | Lyell Immunopharma vs. HCW Biologics | Lyell Immunopharma vs. RenovoRx | Lyell Immunopharma vs. Scpharmaceuticals |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. RenovoRx | Mineralys Therapeutics, vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |